  How genes affect tissue scale organization remains a longstanding biological
puzzle. As experimental efforts are underway to solve this puzzle via
quantification of gene expression and sub-cellular, cellular and tissue
structure, computational efforts remain far behind. To potentially help
accelerate the computational efforts, we review two recent publications, the
first on a cellular-based model for tissues and the second on a cell nucleus
model consisting of chromatin and a lamina shell. We then give a perspective on
how the two models can be combined to test multiscale hypotheses linking the
chromatin scale and the tissue scale. To be concrete, we turn to an in vitro
system for the brain known as a brain organoid. We provide a multiscale
hypothesis to distinguish structural differences between brain organoids built
from induced-pluripotent human stem cells and from induced-pluripotent gorilla
and chimpanzee stem cells. Recent experiments discover that a cell fate
transition from neuroepithelial cells to radial glial cells includes a new
intermediate state that is delayed in human-derived brain organoids as compared
to their genetically-close relatives, which significantly narrows and lengthens
the cells on the apical side [1]. Additional experiments revealed that the
protein ZEB2 plays a major role in the emergence of this new intermediate state
with ZEB2 mRNA levels peaking at the onset of the emergence [1]. We postulate
that the enhancement of ZEB2 expression driving this intermediate state is
potentially due to chromatin reorganization. More precisely, there exists
critical strain triggering the reorganization that is higher for human-derived
stem cells, thereby resulting in a delay. Such a hypothesis can readily be
tested experimentally within individual cells and within brain organoids as
well as computationally to work towards solving the gene-to-tissue organization
puzzle.
